 | Haloperidol | IC50 | 0.16 [1], 0.7 [2] |
| Haloperidol | Ki | 0.66 [1], 0.89 [2], 2.0 [3], 2.5 [4], 2.84 [5] |
 | Clozapine | IC50 | 9.0 [1], 113.0 [2], 204.17 [3], 230.0 [4], 260.0 [5] |
| Clozapine | Ki | 130.0 [1], 144.0 [2], 220.0 [3] |
 | Aripiprazole | IC50 | 7.6 [1], 11.0 [2], 17.2 [3], 32.0 [4] |
 | Quinpirole | IC50 | 462.0 [1] |
| Quinpirole | Ki | 35.0 [1], 63.0 [2], 3000.0 [3], 3100.0 [4] |
 | Dopamine | IC50 | 0.0 [1] |
| Dopamine | Ki | 572.0 [1] |
 | Olanzapine | Ki | 10.0 [1], 78.0 [2] |
 | Apomorphine | IC50 | 4.2 [1], 117.0 [2] |
 | Risperidone | IC50 | 7.09 [1] |
| Risperidone | Ki | 1.4 [1], 6.4 [2] |
 | 3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo[2,3-b]pyridine | Ki | 960.0 [1] |
 | 3-[[4-(4-Chlorophenyl)piperazin-1-yl]methyl]pyrazolo[1,5-a]pyridine | Ki | 3200.0 [1], 4300.0 [2] |
 | 2-[4-(4-Chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine | Ki | 6000.0 [1], 6300.0 [2] |
 | N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-1-benzothiophene-2-carboxamide | IC50 | 94.7 [1] |
| N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-1-benzothiophene-2-carboxamide | Ki | 42.5 [1], 64.7 [2] |
 | Pramipexole | IC50 | 10000.0 [1] |
| Pramipexole | Ki | 21.0 [1], 1900.0 [2], 6300.0 [3] |
 | N-[4-[2-(6-Cyano-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]cyclohexyl]quinoline-4-carboxamide | Ki | 1050.0 [1] |
 | 2-Naphthalenecarboxamide, N-(4-(4-(2-methoxyphenyl)-1-piperazinyl)butyl)- | Ki | 61.0 [1] |
 | Spiperone | IC50 | 0.0 [1], 0.25 [2], 2.56 [3] |
 | Ziprasidone | IC50 | 5.0 [1] |
 | Butaclamol | IC50 | 0.0 [1], 8.9 [2], 12.0 [3], 15.0 [4] |
| Butaclamol | Ki | 0.37 [1], 0.5 [2], 0.6 [3], 2.58 [4] |
 | Cariprazine | IC50 | 1.7 [1] |
 | N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-9H-fluorene-2-carboxamide | IC50 | 1280.0 [1] |
| N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-9H-fluorene-2-carboxamide | Ki | 112.0 [1], 698.0 [2] |
 | Chlorpromazine | IC50 | 1.0 [1], 12.0 [2] |
 | N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)benzofuran-2-carboxamide | IC50 | 118.0 [1] |
| N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)benzofuran-2-carboxamide | Ki | 44.8 [1], 119.0 [2] |
 | CID 11477180 | IC50 | 80.9 [1] |
| CID 11477180 | Ki | 93.3 [1], 106.0 [2] |
 | (S)-7-Dipropylamino-5,6,7,8-tetrahydro-indolizine-3-carbaldehyde | Ki | 41.0 [1], 52.0 [2], 3000.0 [3], 6900.0 [4] |
 | Melanostatin | Ki | 0.13 [1] |
 | Bifeprunox | IC50 | 2.9 [1] |
 | 3-(4-(4-Chlorophenyl-4-hydroxypiperidino)methyl)indole | IC50 | 4.46 [1] |
 | 7-Methyl-6,7,8,9,14,15-hexahydro-5H-benz[d]indolo[2,3-g]azecine | Ki | 19.0 [1] |
 | (3S,6R,8Ar)-5-oxo-1'-[(2S)-pyrrolidine-2-carbonyl]spiro[3,7,8,8a-tetrahydro-2H-[1,3]thiazolo[3,2-a]pyridine-6,2'-pyrrolidine]-3-carboxamide | Ki | 0.2 [1] |
 | (7R,8Ar)-6-oxo-1'-[(2S)-pyrrolidine-2-carbonyl]spiro[3,4,8,8a-tetrahydro-2H-pyrrolo[2,1-b][1,3]thiazine-7,2'-pyrrolidine]-4-carboxamide | Ki | 0.12 [1] |
 | Dopamine hydrochloride | IC50 | 100000.0 [1] |
| Dopamine hydrochloride | Ki | 2.0 [1], 22.0 [2], 56.0 [3], 107.15 [4], 870.96 [5] |
 | Levosulpiride | IC50 | 0.0 [1] |
| Levosulpiride | Ki | 43.0 [1], 51.0 [2], 120.0 [3] |
 | l-Stepholidine | IC50 | 4380.0 [1] |
| l-Stepholidine | Ki | 11.0 [1], 56.17 [2], 105.41 [3], 974.0 [4] |
 | 4-[3-(4-Chlorophenyl)-3-hydroxy-8-azabicyclo[3.2.1]oct-8-yl]-1-(4-fluorophenyl)butan-1-one | Ki | 0.31 [1] |
 | 11-Methyl-11-azatricyclo[12.4.0.03,8]octadeca-1(18),3(8),4,6,14,16-hexaen-6-ol | Ki | 33.5 [1] |
 | N-[4-[4-[2-Tert-butyl-6-(trifluoromethyl)pyrimidin-4-yl]piperazin-1-yl]butyl]imidazo[1,2-a]pyridine-2-carboxamide | IC50 | 111.0 [1], 261.0 [2], 2300.0 [3] |
| N-[4-[4-[2-Tert-butyl-6-(trifluoromethyl)pyrimidin-4-yl]piperazin-1-yl]butyl]imidazo[1,2-a]pyridine-2-carboxamide | Ki | 148.0 [1], 511.0 [2], 702.0 [3] |
 | 8-OH-Dpat | IC50 | 1000.0 [1] |
| 8-OH-Dpat | Ki | 84.0 [1], 86.0 [2], 3243.0 [3] |
 | 7-(Dipropylamino)-5,6,7,8-tetrahydronaphthalen-2-ol | Ki | 2.27 [1], 142.0 [2], 143.0 [3], 202.0 [4] |
 | (+)-Butaclamol | IC50 | 1.1 [1], 5.0 [2] |
| (+)-Butaclamol | Ki | 0.04 [1], 0.27 [2] |
 | N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide | IC50 | 92.0 [1] |
| N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide | Ki | 24.8 [1], 61.2 [2] |
 | N-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)benzofuran-2-carboxamide | Ki | 84.0 [1], 109.65 [2], 110.0 [3], 170.0 [4] |
 | Propylnorapomorphine hydrochloride | Ki | 0.07 [1], 0.11 [2], 0.38 [3], 1.62 [4], 4.9 [5] |
 | US8748608, 34 Enantiomer A | IC50 | 4400.0 [1] |
| US8748608, 34 Enantiomer A | Ki | 746.0 [1], 750.0 [2] |
 | 4-[4-(4-Chlorophenyl)piperazin-1-yl]-1-(4-fluorophenyl)butan-1-one | Ki | 61.0 [1], 63.0 [2], 253.3 [3], 253.5 [4], 254.0 [5] |
 | 6-Methoxy-11-methyl-11-azatricyclo[12.4.0.03,8]octadeca-1(18),3(8),4,6,14,16-hexaene | Ki | 0.55 [1], 12.88 [2], 13.0 [3] |
 | N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)but-2-enyl)-9H-fluorene-2-carboxamide | Ki | 168.0 [1], 198.0 [2], 10000.0 [3] |
 | 1-Phenyl-4-((1-phenyl-1H-pyrazol-4-yl)methyl)piperazine | Ki | 75.0 [1], 140.0 [2], 141.25 [3] |
 | N-[2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl]pyrazolo[1,5-a]pyridine-3-carboxamide | Ki | 85.0 [1], 140.0 [2], 288.4 [3], 290.0 [4] |
 | N-[3-[4-(2-Methoxyphenyl)piperazin-1-yl]propyl]pyrazolo[1,5-a]pyridine-3-carboxamide | Ki | 3.9 [1], 11.0 [2], 13.0 [3], 83.0 [4] |
 | 11-Methyl-11-azatricyclo[12.4.0.03,8]octadeca-1(18),3,5,7,14,16-hexaene | Ki | 8.47 [1], 56.5 [2], 58.88 [3] |
 | Dipropyl-(R)-4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyridin-5-yl-amine | Ki | 20000.0 [1], 53000.0 [2], 55000.0 [3], 57000.0 [4] |
 | (10R)-10-(Dipropylamino)-3-propyl-1,3-diazatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-trien-2-one | IC50 | 98.9 [1], 157.8 [2], 931.1 [3] |
| (10R)-10-(Dipropylamino)-3-propyl-1,3-diazatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-trien-2-one | Ki | 2.59 [1], 146.0 [2] |
 | 1-[[3-Methoxy-4-[3-[1-[8-[4-[3-[2-methoxy-4-[[4-(2-methoxyphenyl)piperazin-1-yl]methyl]phenoxy]propyl]triazol-1-yl]octyl]triazol-4-yl]propoxy]phenyl]methyl]-4-(2-methoxyphenyl)piperazine | Ki | 22.0 [1], 35.0 [2], 41.0 [3] |
 | 1-[[4-[3-(1-Butyltriazol-4-yl)propoxy]-3-methoxyphenyl]methyl]-4-(2-methoxyphenyl)piperazine | Ki | 12.0 [1], 53.0 [2], 67.0 [3] |
 | N-[4-[[(1R)-4-Ethynylcyclohex-3-en-1-yl]-propylamino]butyl]-4-phenylbenzamide | Ki | 0.6 [1], 8.8 [2], 11.0 [3], 14.0 [4], 18.0 [5] |
 | N-[4-[[(1S)-4-Ethynylcyclohex-3-en-1-yl]-propylamino]butyl]-4-phenylbenzamide | Ki | 1.2 [1], 3.9 [2], 9.4 [3], 14.0 [4], 21.0 [5] |
 | N-[4-[(10R)-10-(Dipropylamino)-2-oxo-1,3-diazatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-trien-3-yl]butyl]-1H-indole-2-carboxamide | IC50 | 712.9 [1], 2013.7 [2], 3647.5 [3], 5000.0 [4] |
| N-[4-[(10R)-10-(Dipropylamino)-2-oxo-1,3-diazatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-trien-3-yl]butyl]-1H-indole-2-carboxamide | Ki | 86.8 [1] |
 | (10R)-10-(Methylamino)-3-[2-[2-[2-(4-phenylbutoxy)ethoxy]ethoxy]ethyl]-1,3-diazatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-trien-2-one | IC50 | 5000.0 [1] |
Calculator
